Gonadorelin
Gonadorelin Acetate · GnRH · LHRH · Factrel · Lutrepulse
Think of it as the conductor of your hormone orchestra.
Gonadorelin is like the maestro of hormone signaling, getting your body's reproductive hormones to perform on cue. It mimics a natural hormone that tells your brain to release signals for other hormones controlling reproduction. When used in a rhythmic, on-and-off fashion, it helps maintain a steady release of these signals, keeping your reproductive system in tune.
It's especially handy for those who need a little help getting their hormonal symphony back on track. For example, it can encourage ovulation in women whose cycles have gone silent. It can also serve as a diagnostic tool, helping to figure out whether the brain or the glands are responsible for certain hormone disruptions.
However, it's not something you can just use freely. Its effects depend a lot on timing and rhythm, much like a well-conducted piece of music. Used continuously, it can actually dampen the very signals it's meant to boost, silencing the orchestra instead of leading it.
Who it's for
- Women struggling with irregular menstrual cycles due to hormonal imbalances
- People undergoing hormone therapy looking for alternative support
- Those needing diagnostic clarity on hormone-related issues
Probably not for you if…
- Individuals who prefer one-and-done solutions over ongoing management
- People uncomfortable with precise, timed treatments
- Anyone looking for a quick fix without medical guidance
Editorial summary for research context · Not medical advice
Mechanism of Action
Gonadorelin is a synthetic decapeptide identical to endogenous gonadotropin-releasing hormone (GnRH/LHRH). It binds GnRH receptors on anterior pituitary gonadotrophs, triggering release of LH and FSH. Physiologic pulsatile administration (every 60-120 minutes) stimulates sustained gonadotropin output, while continuous exposure paradoxically desensitizes the receptor and suppresses the HPTA. FDA-approved in pulsatile formulations (Lutrepulse) for primary hypothalamic amenorrhea and as a diagnostic agent (Factrel) for pituitary function; prescription-only.
Researched Benefits
HPTA support during androgen therapy
Used off-label in men's-health endocrinology as an alternative to HCG for Leydig-cell stimulation during exogenous testosterone therapy, though pulsatile pharmacokinetics make dosing less forgiving.
- [Rastrelli et al. 2018]
Diagnostic pituitary stimulation
Single-dose gonadorelin stimulation test differentiates hypothalamic from pituitary causes of hypogonadotropic hypogonadism.
- [Snyder et al. 1979]
Ovulation induction in hypothalamic amenorrhea
Pulsatile pump delivery restores ovulatory cycles in women with isolated hypothalamic GnRH deficiency.
- [Martin et al. 1993]
Research Protocols
The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.
Adjunct during TRT (physician-directed)
- Dosage
- 100 mcg
- Frequency
- 2-3x weekly
- Timing
- subcutaneous
- Cycle
- 12 weeks
Off-label men's-health protocols administer 100-300 mcg SC 2-3x weekly to provide intermittent LH/FSH stimulation. Unlike HCG, gonadorelin has a very short half-life (~4 minutes) and true physiologic mimicry requires pulsatile delivery, which limits its practical equivalence to HCG in many clinical settings.
Pulsatile fertility induction (physician-directed)
- Dosage
- 5 mcg
- Frequency
- every 90 minutes via pump
- Timing
- continuous pulsatile IV or SC
- Cycle
- 4 weeks
Classic fertility protocol delivers 5-20 mcg per pulse every 60-120 minutes via programmable pump. Requires fertility-specialist supervision.
Reported Side Effects
- Injection-site reactions
- Headache
- Flushing
- Nausea
- Rare hypersensitivity / anaphylactoid reactions (more common with repeated IV use)
- Pituitary desensitization with continuous (non-pulsatile) high-dose exposure
Contraindications
- Known hypersensitivity to gonadorelin
- Conditions worsened by reproductive hormone elevation (e.g., hormone-sensitive tumors)
- Pregnancy
- Ovarian cysts not attributable to polycystic ovarian disease
Stacking Partners
Peptides commonly paired with Gonadorelin in published research and protocol write-ups.
Vendor Pricing
Stacked earns a commission on purchases via these links. It does not influence our Trust Scores.
Gear + Companions
Reconstitution supplies and research-backed supplement companions for Gonadorelin. Editorial picks only — we earn a commission through Amazon on the click, no sponsorship.
Gear you'll need
· Reconstitution + storage essentialsBacteriostatic Water 30mL (0.9% Benzyl Alcohol)
Empower Pharmacy / generic medical supply
Reconstitutes every lyophilized peptide. 28-day viability refrigerated.
Insulin Syringes 31G × 5/16" × 0.5mL (100 count)
EasyTouch
31G × 0.5mL insulin syringes — the default size for sub-0.25mL peptide doses.
Alcohol Prep Pads (Sterile, 200 count)
Dynarex
Sterile 70% IPA prep pads — one per vial stopper + one per injection site.
1-Quart Sharps Disposal Container
BD / Becton Dickinson
FDA-cleared sharps container — pharmacies won't accept improvised disposal.
As an Amazon Associate we earn from qualifying purchases · Disclosed per FTC guidelines
Top Videos
Curated from YouTube — refreshed weekly. Stacked doesn't host or endorse external content.
6:13You Won't Believe the Hidden Benefits of PT-141 for Sexual Desire
Rena Malik, M.D.
373.2K views · 6:13 · 3 years ago
15:20What are the medications available to treat low testosterone? | Peter Attia & Mohit Khera
Peter Attia MD
196.7K views · 15:20 · 2 years ago
4:50Will TRT Make Me Gain Muscle? // Testosterone Replacement Therapy Questions
Jacob Godar
137.1K views · 4:50 · 3 years ago
4:57Testosterone Cycle: Must Watch!
Dr James
103.3K views · 4:57 · 2 years ago
9:59hCG Use with Testosterone: Facts vs. Myths - Doctor's Analysis
Testosteronology® Health Portal / Anabolic Doc
99.5K views · 9:59 · 3 years ago
Research Papers
Pulsatile gonadorelin therapy in men with isolated hypogonadotropic hypogonadism
Liu PY, et al. · Journal of Clinical Endocrinology & Metabolism · 2002
PubMed 12213876 →Gonadotropin-releasing hormone pulsatile therapy for induction of ovulation
Martin KA, et al. · Journal of Clinical Endocrinology & Metabolism · 1993
PubMed 8432770 →



